DEC 07 2020: Bio-Pharmaceutical Products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.
Bio-pharmaceuticals Industry in India (2018-2023)
Market insights:
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.
To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/bio-pharmaceuticals-market-in-india-2017/request-sample
Bio-pharmaceutical products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.
Bio-pharmaceuticals Industry in India (2018-2023)
Market insights:
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.
Government initiatives and investments:
The major investors in the Indian bio-pharmaceutical market are AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. In 2017, 46 mergers and acquisition (M&A) deals were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn. The Indian government has taken the initiative to set up an electronic platform for regulating online pharmacies. 'Pharma Vision 2020' has been unveiled so that India can emerge as a global leader in terms of end-to-end drug manufacturing.
Key growth drivers of the market:
India comprises of ~0.13 Mn highly skilled and experienced scientists who serve as a strong support system for the business process of the bio-pharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant center for bio-pharmaceutical research and development (R&D), especially for vaccine manufacturing.
The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India (i3) program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country.
Key deterrents to the growth of the market:
It often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process.
Also, the Indian bio-pharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.
Companies covered:
- Biocon Ltd.
- Cadila Healthcare Ltd.
- Reddy's Laboratories Ltd.
- Panacea Biotec Ltd.
- Wockhardt Ltd.
- GSK Pharmaceuticals Ltd.
- Bharat Biotech International Ltd.
- Bharat Serums and Vaccines Ltd.
- Indian Immunologicals Ltd.
- Serum Institute of India Pvt. Ltd.
To Browse Full Research Report @:
https://www.radiantinsights.com/research/bio-pharmaceuticals-market-in-india-2017
Table of Contents
Chapter 1: Executive summary
Chapter 2: Socio-economic indicators
Chapter 3: Introduction
1.1. Bio-pharmaceuticals market definition and structure
1.2. Bio-pharmaceuticals value chain
Chapter 4: Global pharmaceuticals market
4.1. Market overview
4.2. Market segmentation
4.2.1. Pharmaceuticals market value - country-wise split (2017)
- USA
- Japan
- China
- Germany
- France
- Others
4.2.2. Pharmaceutical spending - region-wise split (2020e)
USA
EU-5
Others
4.2.3. Pharmaceuticals market players - ranking (2017)
4.3. Bio-pharmaceuticals sales growth (2007-2017)
Chapter 5: India bio-pharmaceuticals market
5.1. Market overview
5.2. Market size and growth forecast - value-wise (FY 2016-FY 2023e)
5.3. Market segmentation
5.3.1. Revenue-wise market breakup (FY 2016)
5.3.2. Top five pharmaceutical company market share (2018)
Continued……………….
To See More Reports of This Category by Radiant Insights:
https://latestmarkettrends.news.blog/
About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: [email protected]
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
https://marketsandtrendsreport.blogspot.com/
The statistical surveying report on the global Bio Pharma Buffer Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.
The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.
The statistical data derived from authentic resources and assisted by industry experts.
It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.The global Bio Pharma Buffer market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels.
For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.Get FREE Sample Report Copy @ https://www.decisiondatabases.com/contact/download-sample-43044According to this study, over the next five years, the Bio Pharma Buffer market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 920 million by 2025, from US$ 680 million in 2020.
The Global Blood-Brain Barrier (BBB) Market Size, Share & Growth Analysis By Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer), By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, Others), By End-Use (Hospitals, Surgical centers, Research Institutes, Others) And Regional Forecast, 2021-2027 This research & consulting report doles out information about the global Blood-Brain Barrier (BBB) market.
The Blood-Brain Barrier (BBB) industry is witnessing impressive expansion at present, having logged double digit CAGRs in the past.Read more: https://www.eternityinsights.com/report/blood-brain-barrier-bbb-marketThe report alludes to the Blood-Brain Barrier (BBB) market as a lucrative sector.
Investments by rivals into Blood-Brain Barrier (BBB) products have catapulted the market into limelight & have stoked its demand, globally.Few among other key aspects that find a mention; encompass the industry segments, predictions, & size and shares for 2021 to 2027.
Besides these; the report narrows down on the innovative trends & technological developments, expansion strategies of key players, and regional statistics.Some of the companies for Blood-Brain Barrier (BBB) market are:2-BBB2X Oncology4P TherapeuticsAB ScienceAbbottAbbVieAblynxAC ImmuneACADIA PharmaceuticalsAcceraAcelotAcorda TherapeuticsActinogen MedicalAcumen PharmaceuticalsAdamas PharmaceuticalsAddex TherapeuticsAdvanced Accelerator ApplicationsAdvanced BioHealingAeolus PharmaceuticalsAescap VenturesAestas PharmaAffectis PharmaceuticalsAFFiRiSAgate Medical InvestmentsAgeneBioAgoranovAiCurisAix-Marseille UniversityAlaska Permanent FundAlcyone LifesciencesAlectorRequest Free Sample: https://www.eternityinsights.com/request-a-sample/34809AlkahestAllerganAllinky BiopharmaAlnylam PharmaceuticalsAlzinovaAlzProtectAMAbioticsAmarantus TherapeuticsAmerican Cancer SocietyAmerican Life Science PharmaceuticalsAmgenAmylyx PharmaceuticalsAnavex Life SciencesAngiochemAntea GroupAntoxisAphiosApoPharmaAPRINOIA TherapeuticsAraclon BiotechArbor PharmaceuticalsARCH Venture PartnersArcher PharmaceuticalsArmaGenARMGO PharmaArQuleAsk For Discount: https://www.eternityinsights.com/ask-for-discount/34809Array BioPharmaArrien PharmaceuticalsArrowhead PharmaceuticalsArtengaAsceneuronASCIL BiopharmASEBIOAstellas PharmaAstraZenecaAtlas VentureaTyr PharmaAurin BiotechAusio PharmaceuticalsAutifony TherapeuticsAvanir PharmaceuticalsAxon NeuroscienceAxovant SciencesAxsome TherapeuticsAZTherapiesBach PharmaBaillie GiffordBaxter HealthcareBayerBBB TherapeuticsBDC Venture CapitalBELLUS HealthBenevolentAI BioBen-Gurion UniversityBGN TechnologiesBIAL GroupBIND TherapeuticsBioAdvanceBioAgilytixBioArcticbiOasis TechnologiesBiocatBiocreaBioElectronicsBiogenBiohavenBioLineRxBioMarinBionomicsBiotie TherapiesBiovistaBlueRock TherapeuticsBoehringer IngelheimBoehringer Ingelheim Venture FundBoston ScientificBpiFranceBrain Biomarker SolutionsBrains for Brain FoundationBrainsGateBrainStorm Cell TherapeuticsBrainVectisBrainXBrisco Capital PartnersBristol-Myers SquibbBritannia PharmaceuticalsBroad InstituteCAAP CreationCaixa Capital RiscCantabio PharmaceuticalsEnquiry Before Buy: https://www.eternityinsights.com/enquiry-before-buying/34809Capo TherapeuticsCarna BiosciencesCarTheraCellix BioCenna BiosciencesCENTOGENECerecin (formerly called Accera)CerecorCereSpirCerevanceCHA BiotechChangchun Huayang High-techChaperone TherapeuticsChipscreenChronos TherapeuticsCinnaGenCipio PartnersCleraClevexelCNRS InnovationCobra BiologicsCogentis TherapeuticsCognition TherapeuticsCognosciCollaborative Medicinal DevelopmentColumbia UniversityContera PharmaCoPlex TherapeuticsCorium InternationalCornell UniversityCortexymeCortice BiosciencesRead more: https://www.eternityinsights.com/report/blood-brain-barrier-bbb-marketCorvitexCrinetics PharmaceuticalsCuraSen TherapeuticsCuremarkCyclenium PharmaDAE HWA PharmaceuticalDaewoong PharmaceuticalDainippon Sumitomo PharmaDart PharmaDebiopharmDeciphera PharmaceuticalsDEKK-TECDelMar PharmaceuticalsDenali TherapeuticsDermaXonDexcomDomain TherapeuticsDong-A STEdunn BiotechnologyEight Roads VenturesEIP PharmaEisaiElan PharmaceuticalsEli LillyElron Electronic IndustriesEMD SeronoEMulate TherapeuticsEnhanX BiopharmEnterinE-Scape BioEthrisAsk For Discount: https://www.eternityinsights.com/ask-for-discount/34809More Inputs & ObjectivesThe manner in which nascent & local competitors stack up against prominent players, hogs the spotlight.
For the purpose of this study, Eternity Insights has segmented the global Blood-Brain Barrier (BBB) market on the basis of SMEs, large enterprises, others and region:Blood-Brain Barrier (BBB) Market, By ApplicationAlzheimer’s DiseaseEpilepsyParkinson’s DiseaseMultiple SclerosisHunter’s SyndromeBrain CancerBlood-Brain Barrier (BBB) Market, By TypeBispecific Antibody RMT ApproachTrojan Horse ApproachIncreasing PermeabilityPassive DiffusionOthersEnquiry Before Buy: https://www.eternityinsights.com/enquiry-before-buying/34809Blood-Brain Barrier (BBB) Market, By End-UserHospitalsSurgical CentersResearch InstitutesOthersBlood-Brain Barrier (BBB) Market, By Regional OutlookNorth AmericaS.CanadaMexicoEuropeGermanyUKFranceRest of EuropeRest of the WorldLatin AmericaMiddle East & AfricaAsia PacificChinaJapanIndiaRest of Asia PacificResearch MethodologyResearch methodology is an integral component of any kind of high-level market research.
Secondary research deeply focuses on the whys, whos, wheres, whens, & hows and caters to answering the strictly consumer-centric base of people.Some other secondary research sources comprise governmental affiliations & blogs, business magazines, and industrial journals.
The worldwide Bio Vanillin Market is anticipated to surpass USD 226 million by 2024.
Application in areas, such as cosmetics, pharmaceuticals, and food & beverages will catapult demand in the forthcoming years.The support and encouragement of food regulatory authorities in North America and Europe will impact the market positively.
Regulatory standards that discourage synthetic products may encourage industrial demand.
For instance, there is lower toxicity, minimal emission of greenhouse gases, and lesser energy consumption.
These factors make biotechnological methods a ‘greener’ alternative.Browse Details of Report @ https://www.hexaresearch.com/research-report/bio-vanillin-marketThe global bio vanillin industry is still in its infancy.
As per regulations of the European Parliament and the Council, bio vanillin produced by biotechnological methods using natural inputs are termed ‘natural flavoring’.
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.Marine organisms are potential source for drug discovery.
Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates.
This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-marine-pharmaceuticals-2019-2024-398North America is the largest consumption market of Marine Pharmaceuticals, with sales market share nearly 33.4% in 2018.
The second place is Europe; following North America with the sales market share over 23.3%, China and Japan are also an important sales area.
In 2018, The global marine pharmaceuticals market will observe steady growth because of the robust growth in APAC during the forecast period.
But, the market shares of the Americas and EMEA will decline to some extent during the forecast period.
